Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System

RT @FrontOncology: New research: Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal canc…

Our new Original Research!🎉 👇🏽

RT @FrontOncology: New research: Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal canc…

New research: Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System: Introduction New oral tyrosine kinase inhibitors (TKIs) are… https://t.co/